Building on previous studies which suggested that c-Myc is the critical mediator of JQ1's anti-cancer effects, we next used qRT-PCR and western blots to examine whether JQ1 treatment inhibited c-Myc expression in HCC cells. Here, MYC is linked to hepatocellular carcinoma.